SG50507A1 - Indole derivates as 5-ht1a and/or 5-ht2 ligands - Google Patents

Indole derivates as 5-ht1a and/or 5-ht2 ligands

Info

Publication number
SG50507A1
SG50507A1 SG1996002949A SG1996002949A SG50507A1 SG 50507 A1 SG50507 A1 SG 50507A1 SG 1996002949 A SG1996002949 A SG 1996002949A SG 1996002949 A SG1996002949 A SG 1996002949A SG 50507 A1 SG50507 A1 SG 50507A1
Authority
SG
Singapore
Prior art keywords
ht1a
ligands
derivates
indole
indole derivates
Prior art date
Application number
SG1996002949A
Other languages
English (en)
Inventor
Quintero Myrna Gil
Vincenzo Martino
Franco Borsini
Carlo Maria Pellegrini
Marco Turconi
Ettore Giraldo
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of SG50507A1 publication Critical patent/SG50507A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
SG1996002949A 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands SG50507A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (1)

Publication Number Publication Date
SG50507A1 true SG50507A1 (en) 1998-07-20

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002949A SG50507A1 (en) 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands

Country Status (20)

Country Link
US (1) US5834493A (hu)
EP (1) EP0694033A1 (hu)
JP (1) JPH08508738A (hu)
CN (1) CN1124960A (hu)
AU (1) AU684276B2 (hu)
BG (1) BG100040A (hu)
BR (1) BR9406206A (hu)
CA (1) CA2160020A1 (hu)
CZ (1) CZ283398B6 (hu)
FI (1) FI954734A0 (hu)
HU (1) HUT74090A (hu)
IL (1) IL109234A (hu)
IT (1) IT1271352B (hu)
NO (1) NO953967L (hu)
NZ (1) NZ265055A (hu)
PL (1) PL310995A1 (hu)
SG (1) SG50507A1 (hu)
SK (1) SK119795A3 (hu)
WO (1) WO1994024125A1 (hu)
ZA (1) ZA942383B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
SK285221B6 (sk) * 1997-05-09 2006-09-07 H. Lundbeck A/S Spôsob výroby sertindolu a medziproduktov
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
DE69918799D1 (de) 1998-01-14 2004-08-26 Uab Res Foundation Birmingham Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
ES2182509T3 (es) * 1998-04-08 2003-03-01 Wyeth Corp Derivados de n-ariloxietilamina para el tratamiento de la depresion.
CN1307576A (zh) * 1998-04-29 2001-08-08 美国家用产品公司 5-羟色胺能药物
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
CN1492863A (zh) * 2000-12-22 2004-04-28 作为5-羟色胺-6配基的杂环基烷基-吲哚或氮杂吲哚化合物
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
JP5894574B2 (ja) * 2010-04-22 2016-03-30 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
ES2727815T3 (es) 2012-04-14 2019-10-18 Intra Cellular Therapies Inc Tratamiento del TEPT y de trastornos del control de impulsos
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
KR102495941B1 (ko) 2013-12-03 2023-02-06 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
MX2016013046A (es) 2014-04-04 2017-02-15 Intra-Cellular Therapies Inc Compuestos organicos.
BR112016023162B1 (pt) 2014-04-04 2022-11-29 Intra-Cellular Therapies, Inc Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
WO2017023894A1 (en) * 2015-08-03 2017-02-09 Raze Therapeutics, Inc. Mthfd2 inhibitors and uses thereof
BR112018015283B1 (pt) 2016-01-26 2023-09-26 Intra-Cellular Therapies, Inc Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
EP3888656A1 (en) 2016-03-25 2021-10-06 Intra-Cellular Therapies, Inc. Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
WO2017172795A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
CA3054841A1 (en) 2017-03-24 2018-09-27 Intra-Cellular Therapies, Inc. Novel compositions and methods
WO2019023063A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
MX2020000968A (es) 2017-07-26 2020-09-28 Intra Cellular Therapies Inc Compuestos organicos.
EP3843738A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS
WO2020047408A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
CA2092112A1 (en) * 1992-03-23 1993-09-24 Nobuyoshi Iwata Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use

Also Published As

Publication number Publication date
HU9502913D0 (en) 1995-11-28
CZ283398B6 (cs) 1998-04-15
PL310995A1 (en) 1996-01-22
JPH08508738A (ja) 1996-09-17
CA2160020A1 (en) 1994-10-27
AU684276B2 (en) 1997-12-11
HUT74090A (en) 1996-11-28
FI954734A (fi) 1995-10-05
ITMI930699A0 (it) 1993-04-08
CN1124960A (zh) 1996-06-19
IL109234A (en) 1998-04-05
WO1994024125A1 (en) 1994-10-27
US5834493A (en) 1998-11-10
NO953967D0 (no) 1995-10-05
ZA942383B (en) 1995-10-09
SK119795A3 (en) 1996-04-03
BG100040A (bg) 1996-03-29
NZ265055A (en) 1996-09-25
IT1271352B (it) 1997-05-27
AU6538294A (en) 1994-11-08
ITMI930699A1 (it) 1994-10-08
IL109234A0 (en) 1994-07-31
EP0694033A1 (en) 1996-01-31
CZ260295A3 (en) 1996-01-17
BR9406206A (pt) 1996-02-06
NO953967L (no) 1995-12-05
FI954734A0 (fi) 1995-10-05

Similar Documents

Publication Publication Date Title
SG50507A1 (en) Indole derivates as 5-ht1a and/or 5-ht2 ligands
HU9402983D0 (en) Indol derivatives
ZA941483B (en) Indole derivatives
GB9308695D0 (en) Peptidyl derivatives
ZA947948B (en) Indole derivatives
ZA947210B (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
GB9306003D0 (en) Divagation alarm
ZA942805B (en) Indole derivatives
GB9401659D0 (en) Cooked article configuration
GB9413772D0 (en) 5-HT1A ligands
HU9402534D0 (en) New naphtoxazine derivatives
GB9322269D0 (en) Seasoning can structure
GB2274282B (en) Piperazine-and piperidine-isoxazole derivatives
ZA946220B (en) Azoxycyanobenzodioxane derivates
GB9302577D0 (en) Indole derivatives
PL300513A1 (en) New kind of cooked ham in the block form
GB9311008D0 (en) Indoles
GB9308360D0 (en) Indoles
GB9324433D0 (en) Indoles
GB9319299D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives
GB9307080D0 (en) Indole derivatives
GB9310092D0 (en) Indole derivatives
GB9307725D0 (en) Substituted ketones